IMPROVING PHARMACEUTICAL SERVICES IN COMMUNITY PHARMACIES: STRATEGIES FOR QUALITY ENHANCEMENT

Authors

  • Kodirov Nizomiddin Daminovich,Tukhtaeva Shokhsanam Kholiqul Kizi Head of the Department of Pharmacognosy and Pharmaceutical Technologies. Samarkand State Medical University. Samarkand Uzbekistan.,resident of the master's program in the direction of organization of pharmacy. Samarkand State Medical University. Samarkand Uzbekistan.

DOI:

https://doi.org/10.55640/

Keywords:

pharmaceutical services, community pharmacy, drug supply, patient-centered care, pharmaceutical counseling, health system efficiency.

Abstract

 The optimization of pharmaceutical services represents a cornerstone for improving public health outcomes and strengthening health systems worldwide. Pharmacies, as the most accessible healthcare facilities, provide not only drug dispensing but also counseling, pharmacovigilance, and preventive health services. This article aims to evaluate existing challenges in community pharmacy services and propose evidence-based strategies for enhancing pharmaceutical care quality. A mixed-methods approach, including literature analysis and practical case studies from developing healthcare systems, highlights the role of regulation, professional training, digital health technologies, and patient-centered models in advancing pharmacy practice. The results indicate that integrated, standardized, and patient-oriented pharmaceutical services contribute significantly to medication safety, rational drug use, and overall health system efficiency.

Downloads

Download data is not yet available.

References

1.Abdukodirova S., Muradova R., Mamarizaev I. PECULIARITIES OF USING POLYOXIDONIUM DRUG IN CHILDREN WITH CHRONIC OBSTRUCTIVE BRONCHITIS //Science and innovation. – 2024. – Т. 3. – №. D5. – С. 213-219.

2.Alnahas, F., et al. (2020). Barriers to pharmaceutical care practice: A systematic review. International Journal of Pharmacy Practice, 28(3), 210–220.

3.European Medicines Agency. (2021). Good distribution and pharmacy practices: Guidance for stakeholders. EMA.

4.Hussain, S., & Ibrahim, M. (2019). Impact of digital health solutions in pharmacy services: Evidence from developing countries. Health Policy and Technology, 8(4), 415–423.

5.International Pharmaceutical Federation (FIP). (2022). Global Pharmacy Workforce Report. The Hague: FIP.

6.Komildzonovich M. I. Clinical, laboratory and instrumental features of acute obstructive bronchitis in frequently ill children //Eurasian Journal of Medical and Natural Sciences. – 2024. – Т. 4. – №. 8. – С. 29-32.

7.Komildzonovich M. I. Clinical, laboratory and instrumental features of acute obstructive bronchitis in frequently ill children //Eurasian Journal of Medical and Natural Sciences. – 2024. – Т. 4. – №. 8. – С. 29-32.

8.Komilzhonovich M. I. Studying the pharmacological effectiveness of the use of the drug" advantan" on the course of atopic dermatitis in children //Research Focus. – 2024. – Т. 3. – №. 2. – С. 239-241.

9.Smith, J., & Patel, R. (2021). Enhancing patient-centered care in community pharmacies: A systematic review. Journal of Pharmaceutical Policy and Practice, 14(2), 120–132.

10.World Health Organization. (2023). WHO guideline on good pharmacy practice. Geneva: WHO.

11.Мамаризаев И. К. Features of the course, morpho-functional and clinical-instrumental indicators of community-acquired pneumonia with myocarditis in children //Узбекский медицинский журнал. – 2024. – Т. 5. – №. 2.

12.Мамаризаев И. К., Абдукадирова Ш. Б., Джураев Ж. Д. THE ROLE OF THE HEMOSTATIC SYSTEM IN THE DEVELOPMENT OF ACUTE OBSTRUCTIVE BRONCHITIS IN CHILDREN AGAINST THE BACKGROUND OF MYOCARDITIS //УЗБЕКСКИЙ МЕДИЦИНСКИЙ ЖУРНАЛ. – 2023. – Т. 4. – №. 5.

Downloads

Published

2025-09-16

Issue

Vol. 4 No. 8 (2025): Journal of Multidisciplinary Sciences and Innovations

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

IMPROVING PHARMACEUTICAL SERVICES IN COMMUNITY PHARMACIES: STRATEGIES FOR QUALITY ENHANCEMENT. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(8), 360-363. https://doi.org/10.55640/

Similar Articles

211-220 of 2146

You may also start an advanced similarity search for this article.